Parkinson's Disease
10
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
Home Use Study of Targeted Mechanical Stimulation for Tremor Relief
EEG Measurements to Capture DBS-induced Electric Potentials
Evaluation of GM101 Injection in Patients With Parkinson's Disease
Clinical Trial of Vildagliptin in Early Parkinson's Disease
Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study
The Relationship Between Homocysteine and Manifestation of Parkinson's Disease Patients
A Single-blind, Randomized, Controlled Clinical Study of Flash Stimulation Therapy in Parkinson's Disease
Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease
fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease